U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT07484191) titled 'Contralateral Claims Study of Clareon Vivity Pro' on March 16.
Brief Summary: The purpose of this study is to test new versions of Clareon Vivity Pro intraocular lenses (IOLs) by comparing them to currently marketed IOLs.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Aphakia
Presbyopia
Intervention:
DEVICE: Clareon Vivity Pro IOL
Investigational UV-absorbing, blue-light filtering (BLF), foldable IOL that provides an extended range of vision from distance to near without increasing the incidence of visual disturbances.
IOLs are implantable medical devices and are intended for long term use over the life...